- Home
- AWH vs PRPO Comparison
AWH vs PRPO Comparison
Compare AWH & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWH
- PRPO
- Stock Information
- Founded
- AWH 1993
- PRPO N/A
- Country
- AWH United States
- PRPO United States
- Employees
- AWH N/A
- PRPO N/A
- Industry
- AWH Medical/Dental Instruments
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- AWH Health Care
- PRPO Industrials
- Exchange
- AWH Nasdaq
- PRPO Nasdaq
- Market Cap
- AWH 10.5M
- PRPO 8.8M
- IPO Year
- AWH N/A
- PRPO N/A
- Fundamental
- Price
- AWH $0.50
- PRPO $6.51
- Analyst Decision
- AWH Buy
- PRPO
- Analyst Count
- AWH 2
- PRPO 0
- Target Price
- AWH $4.40
- PRPO N/A
- AVG Volume (30 Days)
- AWH 100.3K
- PRPO 8.3K
- Earning Date
- AWH 11-14-2024
- PRPO 11-06-2024
- Dividend Yield
- AWH N/A
- PRPO N/A
- EPS Growth
- AWH N/A
- PRPO N/A
- EPS
- AWH N/A
- PRPO N/A
- Revenue
- AWH $8,963,000.00
- PRPO $17,411,000.00
- Revenue This Year
- AWH $11.87
- PRPO $75.18
- Revenue Next Year
- AWH $79.10
- PRPO N/A
- P/E Ratio
- AWH N/A
- PRPO N/A
- Revenue Growth
- AWH N/A
- PRPO 31.31
- 52 Week Low
- AWH $0.38
- PRPO $4.31
- 52 Week High
- AWH $5.65
- PRPO $7.30
- Technical
- Relative Strength Index (RSI)
- AWH 27.14
- PRPO 64.52
- Support Level
- AWH $0.38
- PRPO $6.00
- Resistance Level
- AWH $0.79
- PRPO $6.34
- Average True Range (ATR)
- AWH 0.07
- PRPO 0.37
- MACD
- AWH -0.02
- PRPO 0.09
- Stochastic Oscillator
- AWH 27.91
- PRPO 100.00
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.